| 1 | retinoblastoma 1 (including osteosarcoma) | RB1 | |
| 2 | cyclin G1 | CCNG1 | |
| 3 | TNF receptor-associated factor 5 | TRAF5 | |
| 4 | clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) | CLU | |
| 5 | mitogen-activated protein kinase 9 | MAPK9 | |
| 6 | CD27-binding (Siva) protein | SIVA | |
| 7 | CD69 antigen (p60, early T-cell activation antigen) | CD69 | |
| 8 | zinc finger protein, subfamily 1A, 1 (Ikaros) | ZNFN1A1 | |
| 9 | interleukin 4 receptor | IL4R | |
| 10 | mitogen-activated protein kinase kinase 4 | MAPK4 | |
| 11 | jun D proto-oncogene | JUND | |
| 12 | lymphocyte-specific protein tyrosine kinase | LCK | |
| 13 | small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je) | CCL2 | |
| 14 | ribosomal protein S6 kinase, 70kD, polypeptide 1 | RPS6KB1 | |
| 15 | integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) | ITGAM | |
| 16 | catenin (cadherin-associated protein), beta 1 (88kD) | CTNNA1 | |
| 17 | survival of motor neuron 1, telomeric | SMN1 | |
| 18 | caspase 8, apoptosis-related cysteine protease | CASP8 | |
| 19 | E2F transcription factor 4, p107/p130-binding | E2F4 | |
| 20 | proliferating cell nuclear antigen | PCNA | |
| 21 | cyclin C | CCNC | |
| 22 | phosphodiesterase 4B, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E4) | PDE4B | |
| 23 | interleukin 16 (lymphocyte chemoattractant factor) | IL16 | |
| 24 | adenomatosis polyposis coli | APC | |
| 25 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | ID3 | |
| 26 | Src-like-adapter | SLA | |
| 27 | cyclin-dependent kinase 4 | CDK4 | |
| 28 | early growth response 1 | EGR1 | |
| 29 | transcription factor 12 (HTF4, helix-loop-helix transcription factors 4) | HTF4 | |
| 30 | myeloid cell leukemia sequence 1 (BCL2-related) | MCL1 | |
| 31 | cell division cycle 2, G1 to S and G2 to M | CDC2 | |
| 32 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | |
| 33 | cyclin A2 | CCNA2 | |
| 34 | quinone oxidoreductase homolog | TP53I3 | |
| 35 | interleukin-1 receptor-associated kinase 1 | IRAK1BP1 | |
| 36 | SKI-INTERACTING PROTEIN | SNW1 | |
| 37 | myeloid differentiation primary response gene (88) | MYD88 | |
| 38 | caspase 4, apoptosis-related cysteine protease | CASP4 | |
| 39 | transcription factor 8 (represses interleukin 2 expression) | TCF8 | |
| 40 | apoptosis inhibitor 2 | API2 | |
| 41 | GATA-binding protein 3 | GATA3 | |
| 42 | retinoblastoma-like 2 (p130) | RBL2 | |
| 43 | chemokine (C-X3-C) receptor 1 | CX3CR1 | |
| 44 | interferon (alpha, beta and omega) receptor 1 | IFNAR1 | |
| 45 | FYN-binding protein (FYB-120/130) | FYB | |
| 46 | interleukin 2 receptor, gamma (severe combined immunodeficiency) | IL2RG | |
| 47 | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | CSF2 | |
| 48 | myeloperoxidase | MPO | |
| 49 | apoptosis inhibitor 1 | API1 | |
| 50 | cytochrome P450, subfamily XIX (aromatization of androgens) | CYTP450 | |
| 51 | CBF1 interacting corepressor | CIR | |
| 52 | caspase 7, apoptosis-related cysteine protease | CASP7 | |
| 53 | mitogen-activated protein kinase 8 | MAPK8 | |
| 54 | jun B proto-oncogene | JUNB | |
| 55 | interleukin 3 receptor, alpha (low affinity) | IL3RA | |
| 56 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | NFKBIA | |
| 57 | linker for activation of T cells | LAT | |
| 58 | v-akt murine thymoma viral oncogene homolog 1 | AKT1 |